PNC Financial Services Group’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.99K Buy
1,950
+480
+33% +$1.47K ﹤0.01% 4056
2025
Q1
$2.84K Buy
+1,470
New +$2.84K ﹤0.01% 4250